These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 21265802

  • 1. Glycosylation changes as important factors for the susceptibility to urinary tract infection.
    Taganna J, de Boer AR, Wuhrer M, Bouckaert J.
    Biochem Soc Trans; 2011 Jan; 39(1):349-54. PubMed ID: 21265802
    [Abstract] [Full Text] [Related]

  • 2. The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes.
    Bouckaert J, Mackenzie J, de Paz JL, Chipwaza B, Choudhury D, Zavialov A, Mannerstedt K, Anderson J, Piérard D, Wyns L, Seeberger PH, Oscarson S, De Greve H, Knight SD.
    Mol Microbiol; 2006 Sep; 61(6):1556-68. PubMed ID: 16930149
    [Abstract] [Full Text] [Related]

  • 3. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin.
    Bouckaert J, Berglund J, Schembri M, De Genst E, Cools L, Wuhrer M, Hung CS, Pinkner J, Slättegård R, Zavialov A, Choudhury D, Langermann S, Hultgren SJ, Wyns L, Klemm P, Oscarson S, Knight SD, De Greve H.
    Mol Microbiol; 2005 Jan; 55(2):441-55. PubMed ID: 15659162
    [Abstract] [Full Text] [Related]

  • 4. Fimch antiserum inhibits the adherence of Escherichia coli to cells collected by voided urine specimens of diabetic women.
    Meiland R, Geerlings SE, Langermann S, Brouwer EC, Coenjaerts FE, Hoepelman AI.
    J Urol; 2004 Apr; 171(4):1589-93. PubMed ID: 15017227
    [Abstract] [Full Text] [Related]

  • 5. A flow cytometry-based assay for screening FimH antagonists.
    Scharenberg M, Abgottspon D, Cicek E, Jiang X, Schwardt O, Rabbani S, Ernst B.
    Assay Drug Dev Technol; 2011 Oct; 9(5):455-64. PubMed ID: 21675870
    [Abstract] [Full Text] [Related]

  • 6. Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex.
    Wellens A, Garofalo C, Nguyen H, Van Gerven N, Slättegård R, Hernalsteens JP, Wyns L, Oscarson S, De Greve H, Hultgren S, Bouckaert J.
    PLoS One; 2008 Apr 30; 3(4):e2040. PubMed ID: 18446213
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Receptors for Escherichia coli adhesins in the genitourinary tract in a non-human primate.
    Ishikawa K, Sundelin B, Möllby R, Normark S, Winberg J.
    Scand J Urol Nephrol; 2004 Apr 30; 38(1):3-14. PubMed ID: 15204420
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.
    Thankavel K, Madison B, Ikeda T, Malaviya R, Shah AH, Arumugam PM, Abraham SN.
    J Clin Invest; 1997 Sep 01; 100(5):1123-36. PubMed ID: 9276729
    [Abstract] [Full Text] [Related]

  • 12. Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.
    Palaszynski S, Pinkner J, Leath S, Barren P, Auguste CG, Burlein J, Hultgren S, Langermann S.
    Dev Biol Stand; 1998 Sep 01; 92():117-22. PubMed ID: 9554264
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Discovery of Bacterial Fimbria-Glycan Interactions Using Whole-Cell Recombinant Escherichia coli Expression.
    Day CJ, Lo AW, Hartley-Tassell LE, Argente MP, Poole J, King NP, Tiralongo J, Jennings MP, Schembri MA.
    mBio; 2021 Feb 23; 12(1):. PubMed ID: 33622724
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Catch-bond mechanism of the bacterial adhesin FimH.
    Sauer MM, Jakob RP, Eras J, Baday S, Eriş D, Navarra G, Bernèche S, Ernst B, Maier T, Glockshuber R.
    Nat Commun; 2016 Mar 07; 7():10738. PubMed ID: 26948702
    [Abstract] [Full Text] [Related]

  • 19. Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding.
    Chen SL, Hung CS, Pinkner JS, Walker JN, Cusumano CK, Li Z, Bouckaert J, Gordon JI, Hultgren SJ.
    Proc Natl Acad Sci U S A; 2009 Dec 29; 106(52):22439-44. PubMed ID: 20018753
    [Abstract] [Full Text] [Related]

  • 20. Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli FimH adhesin.
    Weissman SJ, Beskhlebnaya V, Chesnokova V, Chattopadhyay S, Stamm WE, Hooton TM, Sokurenko EV.
    Infect Immun; 2007 Jul 29; 75(7):3548-55. PubMed ID: 17502398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.